<DOC>
	<DOCNO>NCT01164085</DOCNO>
	<brief_summary>Intraocular delivery ketorolac effective mean treat inflammation macular edema prevent structural complication vision loss patient uveitis unable tolerate corticosteroid due side effect .</brief_summary>
	<brief_title>Intravitreal Ketorolac Chronic Uveitis : A Investigational Safety Study</brief_title>
	<detailed_description>A Phase I safety study intravitreal ketorolac patient chronic inflammation complication due inflammation either fail medical therapy tolerate corticosteroid due side effect . Specific Aims 1 . Test safety intraocular injection 4mg ketorolac patient intractable uveitis complication uveitis chronic macular edema unable tolerate corticosteroid due side effect . 2 . Test efficacy intraocular 4m ketorolac treat inflammation structural complication inflammation patient uveitis unable tolerate corticosteroid due side effect .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Uveitis</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<criteria>Adult volunteer Chronic intractable uveitis chronic complication uveitis ( macular edema ) despite maximal medical treatment Unable tolerate corticosteroid due side effect 18 year younger Have active ocular infection Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Inflammation</keyword>
	<keyword>Macular Edema</keyword>
</DOC>